Table 1 Estimated vaccine efficacy (from the June projections) against infection, symptomatic disease, hospital admission and death after one or two doses with either the AstraZeneca ChAdOx vaccine or an mRNA vaccine such as the Pfizer vaccine. Values were taken from PHE reports at the time
From: An assessment of the vaccination of school-aged children in England against SARS-CoV-2
Protection against: | AstraZeneca | Pfizer | ||
|---|---|---|---|---|
| Â | Dose 1 | Dose 2 | Dose 1 | Dose 2 |
Infection | 34% | 71% | 34% | 73% |
Symptoms | 34% | 82% | 34% | 83% |
Hospitalisation | 64% | 90% | 64% | 91% |
Deaths | 60% | 96% | 60% | 96% |